1. Home
  2. BRID vs GNLX Comparison

BRID vs GNLX Comparison

Compare BRID & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRID
  • GNLX
  • Stock Information
  • Founded
  • BRID 1932
  • GNLX 2001
  • Country
  • BRID United States
  • GNLX United States
  • Employees
  • BRID N/A
  • GNLX N/A
  • Industry
  • BRID Specialty Foods
  • GNLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BRID Consumer Staples
  • GNLX Health Care
  • Exchange
  • BRID Nasdaq
  • GNLX Nasdaq
  • Market Cap
  • BRID 93.2M
  • GNLX 85.0M
  • IPO Year
  • BRID N/A
  • GNLX 2023
  • Fundamental
  • Price
  • BRID $10.31
  • GNLX $5.34
  • Analyst Decision
  • BRID
  • GNLX Strong Buy
  • Analyst Count
  • BRID 0
  • GNLX 4
  • Target Price
  • BRID N/A
  • GNLX $18.25
  • AVG Volume (30 Days)
  • BRID 1.5K
  • GNLX 396.9K
  • Earning Date
  • BRID 03-07-2025
  • GNLX 03-31-2025
  • Dividend Yield
  • BRID N/A
  • GNLX N/A
  • EPS Growth
  • BRID N/A
  • GNLX N/A
  • EPS
  • BRID N/A
  • GNLX N/A
  • Revenue
  • BRID $223,645,000.00
  • GNLX $8,000.00
  • Revenue This Year
  • BRID N/A
  • GNLX N/A
  • Revenue Next Year
  • BRID N/A
  • GNLX N/A
  • P/E Ratio
  • BRID N/A
  • GNLX N/A
  • Revenue Growth
  • BRID N/A
  • GNLX N/A
  • 52 Week Low
  • BRID $7.77
  • GNLX $1.60
  • 52 Week High
  • BRID $14.69
  • GNLX $8.67
  • Technical
  • Relative Strength Index (RSI)
  • BRID 49.20
  • GNLX 72.84
  • Support Level
  • BRID $10.28
  • GNLX $4.10
  • Resistance Level
  • BRID $10.51
  • GNLX $5.89
  • Average True Range (ATR)
  • BRID 0.13
  • GNLX 0.54
  • MACD
  • BRID -0.02
  • GNLX 0.14
  • Stochastic Oscillator
  • BRID 47.50
  • GNLX 79.70

About BRID Bridgford Foods Corporation

Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are processing and distribution of frozen products, and processing and distribution of snack food products. It includes products such as biscuits, bread dough items, roll dough items, dry sausage products, and beef jerky. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. It derives a majority of its revenue from snack food products.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.

Share on Social Networks: